ICCC·452525306·US·equity·Healthcare - Biotechnology-Activist
ICCC (IMMUCELL CORP) is held by 13 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($1.4M), RENAISSANCE TECHNOLOGIES LLC ($960,824), Cresset Asset Management, LLC ($856,240). Net institutional sentiment: Mixed.
See how ICCC's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer